Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies

NCT01476657 is registered in ClinicalTrials.gov with SecuraBio as lead sponsor.

NCT NCT01476657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
Lead sponsor
SecuraBio
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2011
Completion date
January 31, 2017
Enrollment
210 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies